~8 spots leftby Dec 2025

Yoga for Idiopathic Pulmonary Fibrosis

(YES-IPF Trial)

Recruiting in Palo Alto (17 mi)
BF
GR
Overseen byGanesh Raghu, MD
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: University of Washington
No Placebo Group
Approved in 1 Jurisdiction

Trial Summary

What is the purpose of this trial?

This study will evaluate whether regular yoga exercises designed specifically for patients with Idiopathic Pulmonary Fibrosis is associated with any change in quality of life. Half of the participants will be randomized to yoga, half to usual care. Yoga was conducted live, virtually, in the setting of the COVID Pandemic.

Research Team

BF

Bridget F Collins, MD

Principal Investigator

University of Washington, Center for Interstitial Lung Diseases

GR

Ganesh Raghu, MD

Principal Investigator

University of Washington, Center for Interstitial Lung Diseases

Eligibility Criteria

This trial is for adults over 18 with Idiopathic Pulmonary Fibrosis who can give informed consent and are followed at the University of Washington Medical Center's Center for Interstitial Lung Disease. Details on who cannot participate are not provided.

Inclusion Criteria

I am 18 or older with IPF and can give informed consent.

Treatment Details

Interventions

  • Yoga (Behavioural Intervention)
Trial OverviewThe study tests if yoga, tailored for those with Idiopathic Pulmonary Fibrosis and conducted virtually, affects their quality of life compared to usual care. Participants will be randomly assigned to either the yoga group or a control group receiving standard care.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Group AExperimental Treatment1 Intervention
Patients randomized to 12 weeks of twice weekly yoga sessions. The yoga exercises have been designed specifically for patients with IPF. Yoga sessions were virtual in the setting of the COVID Pandemic
Group II: Group BActive Control1 Intervention
Patients who are not randomized to yoga sessions will continue with their usual care and usual activities

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Washington

Lead Sponsor

Trials
1,858
Recruited
2,023,000+

Dr. Timothy H. Dellit

University of Washington

Chief Executive Officer since 2023

MD from University of Washington

Dr. Anneliese Schleyer

University of Washington

Chief Medical Officer since 2023

MD, MHA